Autoimmune reactions have long been a concern connected with
Gardisil, the human papillomavirus (HPV) vaccine. It has become common for the
vaccine to be recommended to adolescents and young adults to protect against
sexually transmitted infections, which can also lead to cervical cancer in
females.
Now, according to a recent Kaiser Permanente observational
safety study that followed 189,629 girls ages 9 â€" 26 after receiving the HPV
vaccine, researchers did not find any increase in 16 pre-specified autoimmune
conditions, compared to a matched group of unvaccinated females. The list of
conditions included lupus, juvenile rheumatoid arthritis, type 1 diabetes,
Hashimoto’s disease, acute disseminated encephalomyelitis, immune
thrombocytopenia, Graves’ disease, multiple sclerosis, Gillian-Barre syndrome,
autoimmune hemolytic anemia, neuromyelitis optica, uveitis, optic neuritis,
neuromyelitis optica and other demyelinating diseases of the central nervous
system.
The associations between Gardasil and autoimmune reactions
were the result of case reports that had never before been confirmed by a
large, controlled study. Previous safety data on the HPV vaccine had been
collected from clinical trials, which usually include a highly selected
population with very small sample sizes and too short a time for follow-up.
Data had also been gathered from the Vaccine Adverse Event Reporting System,
but it is difficult to determine from such reports, which lack a proper
comparison group, whether the onset of the autoimmune condition may have
preceded the vaccination.
The Kaiser Permanente study’s findings can now offer some
assurance to patients and their families that “among a large and generalizable
female population, no safety signal for autoimmune conditions was found following
HPV4 vaccination in routine clinical use,” says study lead author Chun Chao,
PhD, in a Comtex press release. This study used in-depth medical chart reviews
to guarantee the accuracy of an autoimmune disease diagnosis, and whether the
disease appeared after the vaccination.
This is good news, especially in correlation with the recent
publication of the Journal of the American Medical Association article, which
reports that seven percent of U.S. teens and adults carry the HPV virus in
their mouths. Some HPV infections are harmless, but others can cause oral
cancers.
Read more here.